Cancer Precursor Conditions and their Detection, An Issue of Hematology/Oncology Clinics of North America (True Publisher)
$45.00
Stay ahead in early cancer detection with Cancer Precursor Conditions and Their Detection, a 2024 release from Elsevier’s acclaimed Hematology/Oncology Clinics of North America series. This expertly curated volume delivers the latest clinical strategies and research insights into identifying and managing precancerous hematologic and oncologic conditions—ideal for oncologists, hematologists, pathologists, and cancer researchers.
Description
Cancer Precursor Conditions and Their Detection (1st Edition, 2024) is a cutting-edge resource designed for healthcare professionals focused on cancer prevention, early diagnosis, and clinical decision-making. Part of Elsevier’s renowned Hematology/Oncology Clinics of North America series, this volume provides comprehensive coverage of precancerous states across hematologic and solid tumors, highlighting evidence-based screening practices, risk stratification, and molecular diagnostics.
This book is a must-have for medical oncologists, hematologists, clinical pathologists, internists, and medical researchers aiming to improve early cancer detection and patient outcomes. Its peer-reviewed content bridges the gap between emerging scientific knowledge and practical clinical implementation.
Key Features and Highlights:
- Focused exploration of cancer precursor conditions across hematologic and solid tumor disciplines.
- Up-to-date guidance on diagnostic biomarkers, genetic predisposition, and surveillance strategies.
- Contributions from leading experts in oncology, hematopathology, and preventive medicine.
- Emphasis on precision medicine, clinical risk assessment, and patient management protocols.
- Richly illustrated with tables, flowcharts, and case examples to enhance clinical applicability.
Major Topics Covered:
- Includes core chapters on:
- Premalignant hematologic disorders such as MGUS, MDS, and CHIP
- Genetic syndromes and inherited cancer predispositions
- Screening and monitoring of solid tumor precursors (e.g., Barrett’s esophagus, colorectal polyps, cervical intraepithelial neoplasia)
- Role of liquid biopsies, imaging, and molecular diagnostics in early detection
About the Author:
Edited by leading clinical and academic experts affiliated with top cancer centers and research institutions, the contributors are internationally recognized for their work in early cancer detection and hematologic malignancies.
Technical Details:
- File Format: PDF
- File Size: Approx. 12–18 MB
- Language: English
- Publisher: Elsevier
- Year of Publication: 2024
- Device Compatibility: Compatible with Kindle, Apple Books, Adobe Digital Editions, Android, Windows, and all major e-reading platforms
Frequently Asked Questions (FAQs)
Q1: Is this book suitable for primary care physicians or only for oncology specialists?
A1: While the book is tailored for oncology and hematology professionals, primary care physicians involved in cancer screening and patient referrals will also benefit from its practical insights into early detection strategies.
Q2: Does the book include the latest recommendations on genetic screening and molecular diagnostics?
A2: Yes, the volume covers current advances in molecular diagnostics, including genetic predisposition testing, liquid biopsy applications, and precision oncology approaches for early intervention.
Additional information
Publisher |
Elsevier |
---|---|
Published Year |
2024 |
Language |
English |
ISBN |
9780443293511, 9780443293504, 0443293503, 0443293511 |
File Size |
6.9 MB |
Edition |
1 |
Reviews
There are no reviews yet.